The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Diagnostics Solution Market Research Report 2025
Synopsis
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate cancer diagnostics solution refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics Solution market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 22860 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
North American market for Prostate Cancer Diagnostics Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Cancer Diagnostics Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Cancer Diagnostics Solution in Age Below 55 is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics Solution.
Report Scope
The Prostate Cancer Diagnostics Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnostics Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Segment by Type
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate cancer diagnostics solution refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics Solution market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 22860 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
North American market for Prostate Cancer Diagnostics Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Cancer Diagnostics Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Cancer Diagnostics Solution in Age Below 55 is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics Solution.
Report Scope
The Prostate Cancer Diagnostics Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnostics Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Segment by Type
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Solution Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Solution Market Perspective (2019-2030)
2.2 Prostate Cancer Diagnostics Solution Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Diagnostics Solution Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Diagnostics Solution Market Dynamics
2.3.1 Prostate Cancer Diagnostics Solution Industry Trends
2.3.2 Prostate Cancer Diagnostics Solution Market Drivers
2.3.3 Prostate Cancer Diagnostics Solution Market Challenges
2.3.4 Prostate Cancer Diagnostics Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Solution Revenue
3.4 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Solution Revenue in 2023
3.5 Prostate Cancer Diagnostics Solution Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics Solution Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Diagnostics Solution Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Diagnostics Solution Market Size (2019-2030)
6.2 North America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics Solution Market Size (2019-2030)
7.2 Europe Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics Solution Market Size (2019-2030)
9.2 Latin America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OPKO
11.1.1 OPKO Company Detail
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.1.5 OPKO Recent Development
11.2 Genomic Health
11.2.1 Genomic Health Company Detail
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.2.5 Genomic Health Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.5.5 Siemens Healthcare Recent Development
11.6 bioMeriux
11.6.1 bioMeriux Company Detail
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.6.5 bioMeriux Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Solution Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.7.5 Roche Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Detail
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.8.5 MDx Health Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Detail
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.9.5 DiaSorin Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Detail
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.10.5 Myriad Genetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)
11.11.5 Ambry Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Solution Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Prostate Cancer Diagnostics Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Prostate Cancer Diagnostics Solution Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Solution Market Share by Region (2019-2024)
Table 10. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Solution Market Share by Region (2025-2030)
Table 12. Prostate Cancer Diagnostics Solution Market Trends
Table 13. Prostate Cancer Diagnostics Solution Market Drivers
Table 14. Prostate Cancer Diagnostics Solution Market Challenges
Table 15. Prostate Cancer Diagnostics Solution Market Restraints
Table 16. Global Prostate Cancer Diagnostics Solution Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Prostate Cancer Diagnostics Solution Market Share by Players (2019-2024)
Table 18. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2023)
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Solution Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Solution Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnostics Solution Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Solution Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2019-2024)
Table 27. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2025-2030)
Table 29. Global Prostate Cancer Diagnostics Solution Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2019-2024)
Table 31. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2025-2030)
Table 33. North America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)
Table 48. OPKO Company Detail
Table 49. OPKO Business Overview
Table 50. OPKO Prostate Cancer Diagnostics Solution Product
Table 51. OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 52. OPKO Recent Development
Table 53. Genomic Health Company Detail
Table 54. Genomic Health Business Overview
Table 55. Genomic Health Prostate Cancer Diagnostics Solution Product
Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 57. Genomic Health Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Prostate Cancer Diagnostics Solution Product
Table 61. Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Beckman Coulter Company Detail
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Prostate Cancer Diagnostics Solution Product
Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Siemens Healthcare Company Detail
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Solution Product
Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 72. Siemens Healthcare Recent Development
Table 73. bioMeriux Company Detail
Table 74. bioMeriux Business Overview
Table 75. bioMeriux Prostate Cancer Diagnostics Solution Product
Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 77. bioMeriux Recent Development
Table 78. Roche Company Detail
Table 79. Roche Business Overview
Table 80. Roche Prostate Cancer Diagnostics Solution Product
Table 81. Roche Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 82. Roche Recent Development
Table 83. MDx Health Company Detail
Table 84. MDx Health Business Overview
Table 85. MDx Health Prostate Cancer Diagnostics Solution Product
Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 87. MDx Health Recent Development
Table 88. DiaSorin Company Detail
Table 89. DiaSorin Business Overview
Table 90. DiaSorin Prostate Cancer Diagnostics Solution Product
Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 92. DiaSorin Recent Development
Table 93. Myriad Genetics Company Detail
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Prostate Cancer Diagnostics Solution Product
Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Company Detail
Table 99. Ambry Genetics Business Overview
Table 100. Ambry Genetics Prostate Cancer Diagnostics Solution Product
Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)
Table 102. Ambry Genetics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnostics Solution Market Share by Type: 2023 VS 2030
Figure 3. Tumor Biomarker Tests Features
Figure 4. Imaging Features
Figure 5. Biopsy Features
Figure 6. Other Features
Figure 7. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Prostate Cancer Diagnostics Solution Market Share by Application: 2023 VS 2030
Figure 9. Age Below 55 Case Studies
Figure 10. Age 55-75 Case Studies
Figure 11. Age Above 75 Case Studies
Figure 12. Prostate Cancer Diagnostics Solution Report Years Considered
Figure 13. Global Prostate Cancer Diagnostics Solution Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Prostate Cancer Diagnostics Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Prostate Cancer Diagnostics Solution Market Share by Region: 2023 VS 2030
Figure 16. Global Prostate Cancer Diagnostics Solution Market Share by Players in 2023
Figure 17. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2023
Figure 19. North America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)
Figure 21. United States Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)
Figure 25. Germany Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Region (2019-2030)
Figure 33. China Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)
Figure 41. Mexico Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)
Figure 45. Turkey Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 48. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 49. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 50. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 51. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 52. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 54. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 55. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 56. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 57. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
